Funding Details
- Awarder
- Inbox
- Date Award
- January 06, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Traction
- Orbis emerged from stealth last year with 26 million euros in seed funding and has now raised 90 million euros in Series A funding.
- Founders
- Sevan Habeshian, Christian Heinis
- Company Description
- Orbis Medicines is a European biotechnology startup focused on developing oral peptide drugs, specifically macrocycles that combine the advantages of small molecule and biologic drugs. The company aims to create oral macrocycles that target diseases already addressed by successful injectable medicines.
- Market
- Pharmaceuticals
- Location
-
Hellerup,
Denmark
- Coinvestors
- NEA, Lilly Ventures, Cormorant Asset Management, Novo Holdings, Forbion, Export and Investment Fund of Denmark
Links